LY-2624587
LY-2624587 is a humanized IgG4 monoclonal antibody antagonist targeting CXCR4. LY-2624587 blocks SDF-1/CXCR4 interaction and SDF-1-induced GTP binding. LY-2624587 significantly inhibits cell migration and induces apoptosis in human lymphoma and leukemia cells. LY-2624587 also inhibits CXCR4 and SDF-1 mediated cell signaling including activation of MAPK and AKT. LY-2624587 can be used for human hematological malignancies like acute myeloid leukemia (AML) research[1][2].
Product Specifications
CAS Number
2125546-89-4
UNSPSC
12352100
Target
Akt; Apoptosis; CXCR; p38 MAPK
Related Pathways
Apoptosis; GPCR/G Protein; Immunology/Inflammation; MAPK/ERK Pathway; PI3K/Akt/mTOR
Field of Research
Cancer
References & Citations
[1]Peng SB, et al. Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-CXCR4 Antibody Induces Apoptosis of Hematologic Malignancies. PLoS One. 2016 Mar 8;11 (3) :e0150585. |[2]Cho BS, et al. Targeting the CXCL12/CXCR4 axis in acute myeloid leukemia: from bench to bedside. Korean J Intern Med. 2017 Mar;32 (2) :248-257.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
CXCR4
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
E5562Hu-01 48 Well
Human Leucine-rich glioma-inactivated protein 1, LGI1 ELISA KIT
Sign In for Pricing
View Details E5562Hu-02 96 Well
Human Leucine-rich glioma-inactivated protein 1, LGI1 ELISA KIT
Sign In for Pricing
View Details E5562Hu-03 5x 96 Tests
Human Leucine-rich glioma-inactivated protein 1, LGI1 ELISA KIT
Sign In for Pricing
View Details E5562Hu-04 10x 96 Tests
Human Leucine-rich glioma-inactivated protein 1, LGI1 ELISA KIT
Sign In for Pricing
View Details